The Collège des médecins du Québec (CMQ) and its experts recently made public their thinking with respect to the hypothesis issued by Dr. Paolo Zamboni in 2009 on the possible link between chronic cerebrospinal venous insufficiency (CCSVI) and multiple sclerosis. The Collège des médecins is of the opinion that, outside the framework of research work, current knowledge does not allow for physicians in Québec to practice this treatment, which, for the time being, is not recognized by the scientific medical community.
Read the full press release here.
Dr. Charles Bernard, President and CEO of the Collège des médecins suggested that we need to wait for results from a number of studies. He also discouraged people from consulting any medical tourism clinics offering Dr. Paolo Zamboni’s treatment.
CMQ Director, Dr. Guy Dumas noted:
“I have been suffering from multiple sclerosis for more than 20 years, and this is not the first time that someone seems to be professing a miracle treatment. I understand the hope being raised by Dr. Zamboni’s hypothesis among people like me afflicted with this disease. However, I urge them to exercise prudence. Patients should not be abandoning their current medications in favour of pursuing an unrecognized treatment. We must be sensible and patient. We must wait for the results of the research presently being carried out before taking any other action.”
The Collège des médecins du Québec is the province’s professional order of physicians. The mission of the Collège is to promote quality medicine in order to protect the public and help improve the health of Québecers.
This post was sourced through Eqentia and our Tech News Feed, sponsored by d’Astous Groupe Conseil.
